PUBLISHED RESEARCH REPORT•Environment: LOCAL

NVDAEquity Research

NVIDIA Corporation (NVDA): Revenue Concentration, Margins, and AI Capex Sustainability

An evidence-driven equity research note analyzing SEC 10-K disclosures, segment gross margins, cloud capex dependencies, and trade restriction risk factors.

Published2026-08-20

Analysis As Of2026-08-20

Reading Time8 min read

Data Confidence 92% Verified

Key Research Takeaways

NVIDIA reported consolidated annual GAAP top-line revenue of $215.94B with GAAP gross margin at 71.07%.
Operating cash flow reached $102.72B and GAAP net income reached $120.07B ($4.90 diluted EPS).
Trailing P/E ratio is marked unavailable due to consensus forward EPS data constraints; absolute Price-to-Sales (P/S) stands at 24.68x.
Primary SEC 10-K disclosures cite TSMC foundry manufacturing dependence and U.S. export licensing restrictions as key operational risks.

Key Financial & Operating Metrics (NVDA)

Stock Price$217.56

GAAP Revenue$215.94B

Gross Margin71.07%

Net Income$120.07B

Trailing P/E

Unavailable

Consensus forward EPS data constrained

Price-to-Sales (P/S)24.68x

Financial Performance & Segment Drivers

NVIDIA Corporation (NVDA) generated $215.94B in annual GAAP top-line revenue for the latest reported fiscal period. Data Center end-market revenue contributed $193.74B, representing 89.7% of total revenue.

Margins and Cash Flow Generation

GAAP gross margin stood at 71.07%, reflecting high pricing power for advanced computing architectures. Operating cash flow reached $102.72B, providing capital durability.

Valuation Assessment

Absolute Price-to-Sales (P/S) stands at 24.68x based on trailing reported revenue. Trailing P/E is marked unavailable due to consensus forward EPS data constraints in official filings.

SEC Filing Risk Disclosures

Primary disclosures in SEC filings highlight: 1. **Foundry Concentration**: Dependence on TSMC for semiconductor fabrication and advanced packaging. 2. **Export Regulation**: BIS regulatory licensing requirements limiting high-performance compute export.

EVIDENCE OBSERVATION

FY2026 Full Year

"Data Center end-market revenue generated $193.74B out of $215.94B total GAAP revenue."

Source: SEC EDGAR 10-K Item 8 (FY2026)•Type: Official SEC Filing

EVIDENCE OBSERVATION

Annual Disclosure

"Third-party foundry manufacturing concentration with TSMC identified as core operational risk."

Source: SEC EDGAR 10-K Risk Factors•Type: Regulatory Risk Factor

STATISTICAL FINDING: NVDA Beta vs. Technology Sector Index

3-Year Weekly Returns

Estimated Beta: 1.35p-value: 0.001 (p < 0.05)

Strong, statistically significant positive association with the Technology Sector Index.

STATISTICAL FINDING: NVDA Beta vs. S&P 500 Market Benchmark

3-Year Weekly Returns

Estimated Beta: 1.62p-value: 0.001 (p < 0.05)

High sensitivity to broad U.S. equity market benchmark movements.

Competing Case Analysis

Supporting Evidence (Bull Case)

Reported annual GAAP top-line revenue expansion to $215.94B with 71.07% gross margins.
Substantial operating cash flow generation ($102.72B) supporting R&D reinvestment.

Risk Factors & Constraints (Bear Case)

Trailing P/E unavailable due to forward EPS consensus gaps; high absolute P/S ratio (24.68x).
Material customer concentration among major cloud service providers (CSPs) AI capex cycles.
Export licensing controls restricting high-performance accelerator shipments to designated foreign markets.

Disclosed Data Limitations & Boundaries

DATA LIMITATION: Consensus Forward EPS Estimates

Consensus analyst forward earnings estimates are unavailable from verified primary SEC feeds; forward P/E ratios are omitted to prevent unsupported speculation.

DATA LIMITATION: Relative Sector Valuation Benchmark

Peer group relative sector valuation distribution unexecuted in current pipeline run; P/S stated strictly as absolute ratio.

Sources & Citation Lineage

SEC EDGAR Form 10-K (NVDA)

Provider: sec_edgar • Role: PRIMARY_SEC_FILING

View Filing

SEC EDGAR Form 10-Q (NVDA)

Provider: sec_edgar • Role: PRIMARY_SEC_FILING

View Filing

Discussion (0)

Discuss the evidence, add context, or offer a counterargument.

Add evidence, offer counterarguments, and react to research insights.

Loading discussion comments...